4//SEC Filing
Klobuchar Michael A 4
Accession 0001127602-22-013522
CIK 0000310158other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 5:07 PM ET
Size
13.7 KB
Accession
0001127602-22-013522
Insider Transaction Report
Form 4
Klobuchar Michael A
EVP - Chief Strategy Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2022-05-04−885→ 1,772 totalFrom: 2022-05-04Exp: 2024-05-04→ Common Stock (885 underlying) - Award
Stock Option (Right to Buy)
2022-05-03+25,243→ 25,243 totalExercise: $87.10From: 2023-05-03Exp: 2032-05-02→ Common Stock (25,243 underlying) - Exercise/Conversion
Common Stock
2022-05-04$87.10/sh+885$77,084→ 15,774.93 total - Tax Payment
Common Stock
2022-05-04$87.10/sh−436$37,976→ 15,338.93 total
Holdings
- 662.657(indirect: By Spouse)
Common Stock - 401(k) Plan
- 6.19(indirect: By Children)
Common Stock
- 6.19(indirect: By Children)
Common Stock
- 823.258(indirect: By 401(k))
Common Stock - 401(k) Plan
Footnotes (5)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Includes shares acquired and dividends earned through April 7, 2022 in the Merck U.S. Savings Plan, a 401(k) plan.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F4]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
- [F5]The option vests and becomes exercisable in equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001871957
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 5:07 PM ET
- Size
- 13.7 KB